ORIC Pharmaceuticals, Inc. (ORIC) News
Track canonical SquawkNews coverage tagged to ORIC, ORIC Pharmaceuticals, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
ORIC - ORIC® Pharmaceuticals Reports Second Quarter 2026 Financial Results and Operational Updates
ORIC - ORIC® Pharmaceuticals Reports Second Quarter 2026 Financial Results and Operational Updates
EARNINGS | Aug 03, 2026, 08:07 PM UTC
L
ORIC oric® Pharmaceuticals announces initiation of himalayas-1 phase 3 trial in mcrpc evaluating rinzimetostat in combination with nubeqa® (
ORIC oric® Pharmaceuticals announces initiation of himalayas-1 phase 3 trial in mcrpc evaluating rinzimetostat in combination with nubeqa® (darolutamide), supported by clinical collaboration with Bayer
EQUITY | Jul 14, 2026, 08:05 PM UTC